E8 Pharmaceuticals, LLC v. Affymetrix, Inc.
538 F. App'x 902
Court of Appeals for the Federal Circuit·Decided November 6, 2013·No. No. 2013-1046·Published·Cited by 1 cases
Opinion
We affirm the judgment of noninfringement in favor of Affymetrix, Inc. and Navi-genics, Inc. We base our decision solely on our agreement with the district court’s construction of the phrase “randomly primed PCR-derived RCG.” We do not reach any other issues raised on appeal.
AFFIRMED
Free access — add to your briefcase to read the full text and ask questions with AI
E8 Pharmaceuticals, LLC v. Affymetrix, Inc., 538 F. App'x 902 (Fed. Cir. 2013).
538 F. App'x 902 (E8 Pharmaceuticals, LLC v. Affymetrix, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.
Related
EMC Corp. v. Pure Storage, Inc.
165 F. Supp. 3d 170 (D. Delaware, 2016)